Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer

被引:10
|
作者
Shi, Jian-yu [1 ]
Bi, Yan-yan [2 ]
Yu, Bian-fang [2 ]
Wang, Qing-feng [3 ]
Teng, Dan [4 ]
Wu, Dong-ning [5 ]
机构
[1] Ping Yi Peoples Hosp, Dept Proctol, Linyi, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Proctol, Jinan, Peoples R China
[3] Liaoning Univ Tradit Chinese Med, Coll Integrat Tradit & Western Med, Dept Basic Pharmacol, Shenyang, Peoples R China
[4] HE Univ, Artificial Intelligence & Big Data Coll, Shenyang, Peoples R China
[5] Chinese Acad Chinese Med Sci, Clin Evaluat Ctr, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
alternative splicing; tumor immune infiltration; prognosis; immunotherapy; colorectal cancer; MICROENVIRONMENT; PDCD4;
D O I
10.3389/fonc.2021.583547
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite extensive research, the exact mechanisms involved in colorectal cancer (CRC) etiology and pathogenesis remain unclear. This study aimed to examine the correlation between tumor-associated alternative splicing (AS) events and tumor immune infiltration (TII) in CRC. We analyzed transcriptome profiling and clinical CRC data from The Cancer Genome Atlas (TCGA) database and lists of AS-related and immune-related signatures from the SpliceSeq and Innate databases, respectively to develop and validate a risk model of differential AS events and subsequently a TII risk model. We then conducted a two-factor survival analysis to study the association between TII and AS risk and evaluated the associations between immune signatures and six types of immune cells based on the TIMER database. Subsequently, we studied the distribution of six types of TII cells in high- and low-risk groups for seven AS events and in total. We obtained the profiles of AS events/genes for 484 patients, which included 473 CRC tumor samples and 41 corresponding normal samples, and detected 22581 AS events in 8122 genes. Exon Skip (ES) (8446) and Mutually Exclusive Exons (ME) (74) exhibited the most and fewest AS events, respectively. We then classified the 433 patients with CRC into low-risk (n = 217) and high-risk (n = 216) groups based on the median risk score in different AS events. Compared with patients with low-risk scores (mortality = 11.8%), patients with high-risk scores were associated with poor overall survival (mortality = 27.6%). The risk score, cancer stage, and pathological stage (T, M, and N) were closely correlated with prognosis in patients with CRC (P < 0.001). We identified 6479 differentially expressed genes from the transcriptome profiles of CRC and intersected 468 differential immune-related signatures. High-AS-risk and high-TII-risk predicted a poor prognosis in CRC. Different AS types were associated with different TII risk characteristics. Alternate Acceptor site (AA) and Alternate Promoter (AP) events directly affected the concentration of CD4T cells, and the level of CD8T cells was closely correlated with Alternate Terminator (AT) and Exon Skip (ES) events. Thus, the concentration of CD4T and CD8T cells in the CRC immune microenvironment was not specifically modulated by AS. However, B cell, dendritic cell, macrophage, and neutrophilic cell levels were strongly correlated with AS events. These results indicate adverse associations between AS event risk levels and immune cell infiltration density. Taken together, our findings show a clear association between tumor-associated alternative splicing and immune cell infiltration events and patient outcome and could form a basis for the identification of novel markers and therapeutic targets for CRC and other cancers in the future.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response
    Xiao, Yizhi
    Gao, Liangqing
    Zhao, Xiaojuan
    Zhao, Wang
    Mai, Lei
    Ma, Chengmin
    Han, Yanzhi
    Li, Xiaofeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 139
  • [2] Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas
    Zhiqiang Wang
    Liping Zhu
    Kesang Li
    Yilan Sun
    Georgios Giamas
    Justin Stebbing
    Ling Peng
    Zhentao Yu
    Cancer Gene Therapy, 2022, 29 : 1418 - 1428
  • [3] Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas
    Wang, Zhiqiang
    Zhu, Liping
    Li, Kesang
    Sun, Yilan
    Giamas, Georgios
    Stebbing, Justin
    Peng, Ling
    Yu, Zhentao
    CANCER GENE THERAPY, 2022, 29 (10) : 1418 - 1428
  • [4] Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma
    Huang, Tianpeng
    Ye, Wei
    Lin, Xuejiao
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [5] Mapping alternative splicing events in colorectal cancer
    Zheng, Yifeng
    Zhong, Guoqiang
    Song, Qiuyu
    Zhang, Haonan
    Wang, Shanping
    Lin, Chuangzhen
    He, Chengcheng
    Li, Mingsong
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [6] Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Tumor Immune Infiltration in Bladder Cancer
    Liu, Gao-Lei
    Luo, Hao
    Liang, Dan-Dan
    Zhong, Li
    Dai, Nan
    Lan, Wei-Hua
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024,
  • [7] Deciphering alternative splicing events and their therapeutic implications in colorectal Cancer
    Ding, Wenbo
    Xiao, Qianni
    Yue, Yanzhe
    Chen, Shuyu
    She, Xiangjian
    Pan, Bei
    Zhou, Linpeng
    Yin, Yujuan
    Li, Youyue
    Wang, Shukui
    Xu, Mu
    CELLULAR SIGNALLING, 2024, 118
  • [8] Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer
    Liu, Jingwei
    Li, Hao
    Shen, Shixuan
    Sun, Liping
    Yuan, Yuan
    Xing, Chengzhong
    JOURNAL OF CANCER, 2018, 9 (10): : 1754 - 1764
  • [9] The Role of Autophagy in Tumor Immune Infiltration in Colorectal Cancer
    Bian-fang, Yu
    Dong-ning, Wu
    Dan, Teng
    Jian-yu, Shi
    Shi-yi, Wang
    Ben-jun, Wang
    Xin, Dong
    Wen-wen, Zhao
    Qing-feng, Wang
    Yan, Zhao
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [10] An integrative framework identifies alternative splicing events in colorectal cancer development
    Bisognin, Andrea
    Pizzini, Silvia
    Perilli, Lisa
    Esposito, Giovanni
    Mocellin, Simone
    Nitti, Donato
    Zanovello, Paola
    Bortoluzzi, Stefania
    Mandruzzato, Susanna
    MOLECULAR ONCOLOGY, 2014, 8 (01) : 129 - 141